← Open Payments lookup

RACHEAL ANEKE: Open Payments

NPI 1073071684 · FOLSOM, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,740 in 70 payments from 15 companies in 2025. Trend: 2023 $526 · 2024 $1,110 · 2025 $1,740

Food & beverage: $1,629Education: $111
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.16$366
Otsuka America Pharmaceutical, Inc.12$323
Neurocrine BioSciences, Inc.11$322
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)11$189
E.R. Squibb & Sons, L.L.C.7$176
Janssen Pharmaceuticals, Inc3$153
Vanda Pharmaceuticals Inc.2$56
Supernus Pharmaceuticals, Inc.1$28
Axsome Therapeutics, Inc.1$25
Almatica Pharma LLC1$21

Products named: INGREZZA, CAPLYTA, COBENFY, UZEDY, INVEGA SUSTENNA, REXULTI, ABILIFY MAINTENA, ABILIFY ASIMTUFII.

Industry payments across CA — which companies pay providers there.